<DOC>
	<DOCNO>NCT02057484</DOCNO>
	<brief_summary>The purpose study evaluate impact Advagraf , prolonged-release , daily tacrolimus formulation , long-term graft survival kidney liver allograft recipient . This study also evaluate overall long-term impact Advagraf kidney liver allograft recipient .</brief_summary>
	<brief_title>A 5 Year Follow-up Patients Who Were Previously Enrolled Into Advagraf Trial Following Liver Kidney Transplant</brief_title>
	<detailed_description>Prograf one medication take patient liver kidney transplant prevent body reject new liver kidney transplant . Prograf take patient twice day . Advagraf similar medication take patient day . There evidence emerging may show once-a-day medication may show additional benefit twice day medication , , patient likely remember take medication . Also , day medication slowly release body course day turn may provide good protection body reject new transplant organ long period . This study follow adult patient previously enrol Advagraf trial liver kidney transplant . The information collect study information patient 's doctor normally collect he/she see patient regular check-ups . Information collect year period 5 year patient receive new organ transplant . It hop patient information collect study provide prescribers useful information treatment organ transplant patient .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Participated one select Astellas sponsor clinical trial : DIAMOND PMREC1106 ADVANCE PMREC1211 ADHERE PMREC1212 Or , potential new Astellassponsored Advagraf trial Assigned treatment Advagraf one select Astellas sponsor clinical trial receive kidney liver organ transplant . NOTE : The primary objective study longterm graft survival patient currently previously treat Advagraf . Therefore patient currently receive Advagraf include , complete previous Astellas clinical trial . No exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>long-term follow-up</keyword>
	<keyword>liver transplant</keyword>
	<keyword>kidney transplant</keyword>
	<keyword>Advagraf</keyword>
</DOC>